Figure - PMC

Skip to main content

An official website of the United States government

Here's how you know

Here's how you know

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

View full-text article in PMC

. 2023 Oct 18;23:1001. doi: 10.1186/s12885-023-11288-1

Search in PMC
Search in PubMed
View in NLM Catalog
Add to search

© The Author(s) 2023

Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.

PMC Copyright notice

Fig. 10 — Validation of the expression levels of EZH2, G6PD, LGALS3 and PSMD14. Protein expression levels of EZH2 in unpaired HCC patient samples (A). Protein expression levels of G6PD in unpaired HCC patient samples (B). Protein expression levels of LGALS3 in unpaired HCC patient samples (C). Protein expression levels of PSMD14 in unpaired HCC patient samples (D). Protein expression levels of EZH2 in paired HCC patient samples (E). Protein expression levels of G6PD in paired HCC patient samples (F). Protein expression levels of LGALS3 in paired HCC patient samples (G). Protein expression levels of PSMD14 in paired HCC patient samples (H). Effect of EZH2 expression on survival of Kaplan-Meyer mapper hepatocellular carcinoma (I). Effect of G6PD expression on survival of Kaplan-Meyer mapper hepatocellular carcinoma (J). Effect of LGALS3 expression on survival of Kaplan-Meyer mapper hepatocellular carcinoma (K). Effect of PSMD14 expression on survival of Kaplan-Meyer mapper hepatocellular carcinoma (l). Representative immunohistochemical staining results of EZH2 protein in hepatocellular carcinoma tissue and normal tissue (M, Q). Representative immunohistochemical staining results of G6PD protein in hepatocellular carcinoma tissue and normal tissue (N, R). Representative immunohistochemical staining results of LGALS3 protein in hepatocellular carcinoma tissue and normal tissue (O, S). Representative immunohistochemical staining results of PSMD14 protein in hepatocellular carcinoma tissue and normal tissue (P, T)